Nigericin
From Wikidoc - Reading time: 2 min
|
WikiDoc Resources for Nigericin |
|
Articles |
|---|
|
Most recent articles on Nigericin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nigericin at Clinical Trials.gov Clinical Trials on Nigericin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nigericin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nigericin Discussion groups on Nigericin Directions to Hospitals Treating Nigericin Risk calculators and risk factors for Nigericin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nigericin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Nigericin is an antibiotic derived from Streptomyces hygroscopicus. Commercially it is obtained as a byproduct, or contaminant, at the fermentation of Geldanamycin. It is also called
Polyetherin A, Azalomycin M, Helixin C, Antibiotic K178, Antibiotic X-464.
Nigericin acts as an H+, K+, Pb++ ionophore. It most commonly is an antiporter of H+ and K+.
In the past Nigericin was used as an antibiotic active against gram positive bacteria. It inhibits the Golgi functions. Nigericin exhibits anti-HIV activity.
Properties[edit | edit source]
- CAS number: 28643-80-3
- Merck index: 12, 6633
- Molecular weight: 747
- Formula C40H67O11Na
The properties are copied from a manufacturer's Nigericin product page]
External references[edit | edit source]
EncycloReader
is supported by the 
KSF